Tuberculosis (TB) Diagnostics Market Report

Japan Tuberculosis (TB) Diagnostics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 15, 2019
  • PAGES：150
  • REPORT CODE：GMM235115
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Tuberculosis (TB) Diagnostics market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Tuberculosis (TB) Diagnostics market. Detailed analysis of key players, along with key growth strategies adopted by Tuberculosis (TB) Diagnostics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Hologic SA

    • Cepheid

    • Hain Lifescience GmbH

    • Sanofi

    • Abbott Laboratories

    • bioMérieux, Inc.

    • Qiagen Corporation

    • QIAGEN

    • Alere, Inc.

    • F. Hoffmann-La Roche AG

    • Becton

    • Dickinson and Company


    By Type:

    • Detection of Latent Infection

    • Radiographic Method

    • Diagnostic Laboratory Methods

    • Cytokine Detection Assay

    • Detection of Drug Resistance

    • Nucleic Acid Testing

    • Other Methods


    By End-User:

    • Hospitals

    • Clinics

    • Reference Laboratories

    • Research Institutes and Academics

    • Others


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Tuberculosis (TB) Diagnostics Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Detection of Latent Infection from 2014 to 2026

      • 1.3.2 Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Radiographic Method from 2014 to 2026

      • 1.3.3 Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Diagnostic Laboratory Methods from 2014 to 2026

      • 1.3.4 Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Cytokine Detection Assay from 2014 to 2026

      • 1.3.5 Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Detection of Drug Resistance from 2014 to 2026

      • 1.3.6 Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Nucleic Acid Testing from 2014 to 2026

      • 1.3.7 Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Other Methods from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Hospitals from 2014 to 2026

      • 1.4.2 Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Clinics from 2014 to 2026

      • 1.4.3 Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Reference Laboratories from 2014 to 2026

      • 1.4.4 Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Research Institutes and Academics from 2014 to 2026

      • 1.4.5 Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Tuberculosis (TB) Diagnostics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Tuberculosis (TB) Diagnostics by Major Types

      • 3.4.1 Market Size and Growth Rate of Detection of Latent Infection

      • 3.4.2 Market Size and Growth Rate of Radiographic Method

      • 3.4.3 Market Size and Growth Rate of Diagnostic Laboratory Methods

      • 3.4.4 Market Size and Growth Rate of Cytokine Detection Assay

      • 3.4.5 Market Size and Growth Rate of Detection of Drug Resistance

      • 3.4.6 Market Size and Growth Rate of Nucleic Acid Testing

      • 3.4.7 Market Size and Growth Rate of Other Methods

    4 Segmentation of Tuberculosis (TB) Diagnostics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Tuberculosis (TB) Diagnostics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Tuberculosis (TB) Diagnostics in Hospitals

      • 4.4.2 Market Size and Growth Rate of Tuberculosis (TB) Diagnostics in Clinics

      • 4.4.3 Market Size and Growth Rate of Tuberculosis (TB) Diagnostics in Reference Laboratories

      • 4.4.4 Market Size and Growth Rate of Tuberculosis (TB) Diagnostics in Research Institutes and Academics

      • 4.4.5 Market Size and Growth Rate of Tuberculosis (TB) Diagnostics in Others


    5 Market Analysis by Regions

    • 5.1 Japan Tuberculosis (TB) Diagnostics Production Analysis by Regions

    • 5.2 Japan Tuberculosis (TB) Diagnostics Consumption Analysis by Regions


    6 Hokkaido Tuberculosis (TB) Diagnostics Landscape Analysis

    • 6.1 Hokkaido Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 6.2 Hokkaido Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users


    7 Tohoku Tuberculosis (TB) Diagnostics Landscape Analysis

    • 7.1 Tohoku Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 7.2 Tohoku Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users


    8 Kanto Tuberculosis (TB) Diagnostics Landscape Analysis

    • 8.1 Kanto Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 8.2 Kanto Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users


    9 Chubu Tuberculosis (TB) Diagnostics Landscape Analysis

    • 9.1 Chubu Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 9.2 Chubu Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users


    10 Kinki Tuberculosis (TB) Diagnostics Landscape Analysis

    • 10.1 Kinki Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 10.2 Kinki Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users


    11 Chugoku Tuberculosis (TB) Diagnostics Landscape Analysis

    • 11.1 Chugoku Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 11.2 Chugoku Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users


    12 Shikoku Tuberculosis (TB) Diagnostics Landscape Analysis

    • 12.1 Shikoku Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 12.2 Shikoku Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users


    13 Kyushu Tuberculosis (TB) Diagnostics Landscape Analysis

    • 13.1 Kyushu Tuberculosis (TB) Diagnostics Landscape Analysis by Major Types

    • 13.2 Kyushu Tuberculosis (TB) Diagnostics Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Hologic SA

      • 14.1.1 Hologic SA Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Cepheid

      • 14.2.1 Cepheid Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Hain Lifescience GmbH

      • 14.3.1 Hain Lifescience GmbH Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Sanofi

      • 14.4.1 Sanofi Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Abbott Laboratories

      • 14.5.1 Abbott Laboratories Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 bioMérieux, Inc.

      • 14.6.1 bioMérieux, Inc. Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Qiagen Corporation

      • 14.7.1 Qiagen Corporation Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 QIAGEN

      • 14.8.1 QIAGEN Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Alere, Inc.

      • 14.9.1 Alere, Inc. Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 F. Hoffmann-La Roche AG

      • 14.10.1 F. Hoffmann-La Roche AG Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Becton

      • 14.11.1 Becton Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Dickinson and Company

      • 14.12.1 Dickinson and Company Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 101 Figures and 173 Tables)

     

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Detection of Latent Infection from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Radiographic Method from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Diagnostic Laboratory Methods from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Cytokine Detection Assay from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Detection of Drug Resistance from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Nucleic Acid Testing from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Other Methods from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Reference Laboratories from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Research Institutes and Academics from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Tuberculosis (TB) Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Tuberculosis (TB) Diagnostics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Tuberculosis (TB) Diagnostics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Tuberculosis (TB) Diagnostics by Different Types from 2014 to 2026

    • Table Consumption Share of Tuberculosis (TB) Diagnostics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Detection of Latent Infection

    • Figure Market Size and Growth Rate of Radiographic Method

    • Figure Market Size and Growth Rate of Diagnostic Laboratory Methods

    • Figure Market Size and Growth Rate of Cytokine Detection Assay

    • Figure Market Size and Growth Rate of Detection of Drug Resistance

    • Figure Market Size and Growth Rate of Nucleic Acid Testing

    • Figure Market Size and Growth Rate of Other Methods

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Tuberculosis (TB) Diagnostics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Tuberculosis (TB) Diagnostics by Different End-Users from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Reference Laboratories from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Research Institutes and Academics from 2014 to 2026

    • Figure Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Tuberculosis (TB) Diagnostics Production by Regions

    • Table Japan Tuberculosis (TB) Diagnostics Production Share by Regions

    • Figure Japan Tuberculosis (TB) Diagnostics Production Share by Regions in 2014

    • Figure Japan Tuberculosis (TB) Diagnostics Production Share by Regions in 2018

    • Figure Japan Tuberculosis (TB) Diagnostics Production Share by Regions in 2026

    • Table Japan Tuberculosis (TB) Diagnostics Consumption by Regions

    • Table Japan Tuberculosis (TB) Diagnostics Consumption Share by Regions

    • Figure Japan Tuberculosis (TB) Diagnostics Consumption Share by Regions in 2014

    • Figure Japan Tuberculosis (TB) Diagnostics Consumption Share by Regions in 2018

    • Figure Japan Tuberculosis (TB) Diagnostics Consumption Share by Regions in 2026

    • Table Hokkaido Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Hokkaido Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Tuberculosis (TB) Diagnostics Consumption Share by Types in 2014

    • Figure Hokkaido Tuberculosis (TB) Diagnostics Consumption Share by Types in 2018

    • Figure Hokkaido Tuberculosis (TB) Diagnostics Consumption Share by Types in 2026

    • Table Hokkaido Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2014

    • Figure Hokkaido Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2018

    • Figure Hokkaido Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2026

    • Table Tohoku Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Tohoku Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Tuberculosis (TB) Diagnostics Consumption Share by Types in 2014

    • Figure Tohoku Tuberculosis (TB) Diagnostics Consumption Share by Types in 2018

    • Figure Tohoku Tuberculosis (TB) Diagnostics Consumption Share by Types in 2026

    • Table Tohoku Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Tohoku Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2014

    • Figure Tohoku Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2018

    • Figure Tohoku Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2026

    • Table Kanto Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Kanto Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Kanto Tuberculosis (TB) Diagnostics Consumption Share by Types in 2014

    • Figure Kanto Tuberculosis (TB) Diagnostics Consumption Share by Types in 2018

    • Figure Kanto Tuberculosis (TB) Diagnostics Consumption Share by Types in 2026

    • Table Kanto Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Kanto Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2014

    • Figure Kanto Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2018

    • Figure Kanto Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2026

    • Table Chubu Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Chubu Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Chubu Tuberculosis (TB) Diagnostics Consumption Share by Types in 2014

    • Figure Chubu Tuberculosis (TB) Diagnostics Consumption Share by Types in 2018

    • Figure Chubu Tuberculosis (TB) Diagnostics Consumption Share by Types in 2026

    • Table Chubu Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Chubu Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2014

    • Figure Chubu Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2018

    • Figure Chubu Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2026

    • Table Kinki Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Kinki Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Kinki Tuberculosis (TB) Diagnostics Consumption Share by Types in 2014

    • Figure Kinki Tuberculosis (TB) Diagnostics Consumption Share by Types in 2018

    • Figure Kinki Tuberculosis (TB) Diagnostics Consumption Share by Types in 2026

    • Table Kinki Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Kinki Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2014

    • Figure Kinki Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2018

    • Figure Kinki Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2026

    • Table Chugoku Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Chugoku Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Tuberculosis (TB) Diagnostics Consumption Share by Types in 2014

    • Figure Chugoku Tuberculosis (TB) Diagnostics Consumption Share by Types in 2018

    • Figure Chugoku Tuberculosis (TB) Diagnostics Consumption Share by Types in 2026

    • Table Chugoku Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Chugoku Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2014

    • Figure Chugoku Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2018

    • Figure Chugoku Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2026

    • Table Shikoku Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Shikoku Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Tuberculosis (TB) Diagnostics Consumption Share by Types in 2014

    • Figure Shikoku Tuberculosis (TB) Diagnostics Consumption Share by Types in 2018

    • Figure Shikoku Tuberculosis (TB) Diagnostics Consumption Share by Types in 2026

    • Table Shikoku Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Shikoku Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2014

    • Figure Shikoku Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2018

    • Figure Shikoku Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2026

    • Table Kyushu Tuberculosis (TB) Diagnostics Consumption by Types from 2014 to 2026

    • Table Kyushu Tuberculosis (TB) Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Tuberculosis (TB) Diagnostics Consumption Share by Types in 2014

    • Figure Kyushu Tuberculosis (TB) Diagnostics Consumption Share by Types in 2018

    • Figure Kyushu Tuberculosis (TB) Diagnostics Consumption Share by Types in 2026

    • Table Kyushu Tuberculosis (TB) Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Kyushu Tuberculosis (TB) Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2014

    • Figure Kyushu Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2018

    • Figure Kyushu Tuberculosis (TB) Diagnostics Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Hologic SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hologic SA

    • Figure Sales and Growth Rate Analysis of Hologic SA

    • Figure Revenue and Market Share Analysis of Hologic SA

    • Table Product and Service Introduction of Hologic SA

    • Table Company Profile and Development Status of Cepheid

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cepheid

    • Figure Sales and Growth Rate Analysis of Cepheid

    • Figure Revenue and Market Share Analysis of Cepheid

    • Table Product and Service Introduction of Cepheid

    • Table Company Profile and Development Status of Hain Lifescience GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hain Lifescience GmbH

    • Figure Sales and Growth Rate Analysis of Hain Lifescience GmbH

    • Figure Revenue and Market Share Analysis of Hain Lifescience GmbH

    • Table Product and Service Introduction of Hain Lifescience GmbH

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of bioMérieux, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of bioMérieux, Inc.

    • Figure Sales and Growth Rate Analysis of bioMérieux, Inc.

    • Figure Revenue and Market Share Analysis of bioMérieux, Inc.

    • Table Product and Service Introduction of bioMérieux, Inc.

    • Table Company Profile and Development Status of Qiagen Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen Corporation

    • Figure Sales and Growth Rate Analysis of Qiagen Corporation

    • Figure Revenue and Market Share Analysis of Qiagen Corporation

    • Table Product and Service Introduction of Qiagen Corporation

    • Table Company Profile and Development Status of QIAGEN

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN

    • Figure Sales and Growth Rate Analysis of QIAGEN

    • Figure Revenue and Market Share Analysis of QIAGEN

    • Table Product and Service Introduction of QIAGEN

    • Table Company Profile and Development Status of Alere, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alere, Inc.

    • Figure Sales and Growth Rate Analysis of Alere, Inc.

    • Figure Revenue and Market Share Analysis of Alere, Inc.

    • Table Product and Service Introduction of Alere, Inc.

    • Table Company Profile and Development Status of F. Hoffmann-La Roche AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche AG

    • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche AG

    • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche AG

    • Table Product and Service Introduction of F. Hoffmann-La Roche AG

    • Table Company Profile and Development Status of Becton

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Becton

    • Figure Sales and Growth Rate Analysis of Becton

    • Figure Revenue and Market Share Analysis of Becton

    • Table Product and Service Introduction of Becton

    • Table Company Profile and Development Status of Dickinson and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dickinson and Company

    • Figure Sales and Growth Rate Analysis of Dickinson and Company

    • Figure Revenue and Market Share Analysis of Dickinson and Company

    • Table Product and Service Introduction of Dickinson and Company

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US